Early hyperglycemia is associated with poor gross motor outcome in asphyxiated term newborns

Erin E Spies1, Suzanne L Lababidi2, Margaret C McBride3

  • 1Department of Pediatrics, Akron Children's Hospital, Akron, Ohio.

Pediatric Neurology
|April 16, 2014
PubMed

Insights

Hyperglycemia, or high blood glucose, in newborns with birth asphyxia is linked to poor gross motor skills. Managing blood sugar levels is crucial for better outcomes in these infants.

Area of Science:

  • Neonatal neurology
  • Pediatric critical care
  • Metabolic disorders

Background:

  • Hyperglycemia is linked to poor neurological outcomes in stroke and near-drowning.
  • In asphyxiated infants, anaerobic glucose metabolism can increase lactic acid and neurological injury.
  • Basal ganglia injury, often seen in asphyxiated newborns, correlates with motor deficits.

Purpose of the Study:

  • To investigate the association between hyperglycemia and gross motor outcome in term infants with birth asphyxia.
  • To determine if elevated blood glucose levels predict poor motor development in this vulnerable population.

Main Methods:

  • Retrospective review of medical records for 41 term infants with asphyxia.
  • Collected data included glucose levels, blood gas values, and demographics.
  • Gross Motor Function Classification System (GMFCS) scores assessed motor outcomes.

Main Results:

  • 14 infants (34%) had poor outcomes (death or moderate-to-severe cerebral palsy).
  • 27 infants (66%) had no gross motor disability (GMFCS score 0).
  • Higher blood glucose levels significantly correlated with poor gross motor outcome (P=0.046). Hyperglycemia (BG > 150 mg/dL) increased the odds of poor outcome (OR: 5.9, P=0.017).

Conclusions:

  • Elevated blood glucose in the first 12 hours post-asphyxia is associated with adverse gross motor outcomes in term infants.
  • Avoiding hyperglycemia is recommended for managing term infants experiencing birth asphyxia.
Abstract

Related Concept Videos

Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K